Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells

Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells

(2016) Anna Klimaszewska-Wisniewska et al.   Cancer Cell International

Phytochemicals for the Management of Melanoma

(2016) Harish Chandra Pal et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model

(2016) Zhi-yong Zhou et al.   TOXICOLOGY LETTERS

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines

(2016) Xiao-Yan Bai et al.   PLoS One

Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways

(2015) GUANMIN MENG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin

(2015) KWANG-YOUN KIM et al.   Molecular Medicine Reports

Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo

(2015) Jing Hu et al.   Oncotarget

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2

(2014) Guodong Xu et al.   BMC Pulmonary Medicine

β-sitosterol induces G1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma MDA-MB-231 cells

(2013) Shanthi Sri Vundru et al.   BMC Complementary and Alternative Medicine

Silibinin reverses drug resistance in human small-cell lung carcinoma cells

(2013) David Sadava et al.   CANCER LETTERS

Acacetin (5,7-dihydroxy-4′-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells

(2013) HYE RI KIM et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Usnic Acid Inhibits Growth and Induces Cell Cycle Arrest and Apoptosis in Human Lung Carcinoma A549 Cells

(2013) Narendra Singh et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft

(2013) Anil Mittal et al.   PHYTOMEDICINE

Phytochemicals As Chemosensitizers: From Molecular Mechanism to Clinical Significance

(2012) Balachandran S. Vinod et al.   ANTIOXIDANTS & REDOX SIGNALING

The Hedgehog Receptor Patched Functions in Multidrug Transport and Chemotherapy Resistance

(2012) M. Bidet et al.   MOLECULAR CANCER RESEARCH

Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer (HeLa) cell line

(2012) Shanmugam Hemaiswarya et al.   PHYTOMEDICINE

Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention

(2011) T. A. Bhat et al.   CARCINOGENESIS

Molecular Biology of Lung Cancer: Clinical Implications

(2011) Jill E. Larsen et al.   CLINICS IN CHEST MEDICINE

The cell cycle and cancer

(2011) Gareth H Williams et al.   JOURNAL OF PATHOLOGY

Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells

(2011) HYUNSOO SHIN et al.   ONCOLOGY REPORTS

Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer

(2010) David J. Stewart   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells

(2008) R. C-Y. Hui et al.   MOLECULAR CANCER THERAPEUTICS

RNA Aptamer-targeted Inhibition of NF-κB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin

(2007) Jing Mi et al.   MOLECULAR THERAPY